[144] US Physical Therapy Inc SEC Filing

Rhea-AI Filing Summary

US Physical Therapy, Inc. (USPH) submitted a Form 144 notifying a proposed sale of 2,000 shares of common stock through UBS Financial Services on the NYSE with an aggregate market value of $165,127.20. The shares were originally acquired as restricted stock grants on 04/01/2020 (3,089 shares acquired) and were paid as compensation on the acquisition date. The filing states there were no securities sold by the reporting person in the past three months. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Full disclosure of proposed sale details including broker, share count, and aggregate market value
• No reported sales by the reporting person in the past three months, as stated in the filing
• Origin of shares disclosed (restricted stock grants acquired 04/01/2020) and payment method (compensation)

Negative

• Insider intends to sell 2,000 shares which will be executed on the NYSE (aggregate value $165,127.20)
• Outstanding share base disclosed (15,200,000) which contextualizes the sale as part of the public float

Insights

Securities Analyst

TL;DR: Insider plans a modest sale of 2,000 shares filed under Rule 144; filing is routine and adheres to disclosure requirements.

This Form 144 documents a proposed sale by a person who received restricted stock grants on 04/01/2020 and intends to sell 2,000 common shares via UBS on the NYSE with an indicated aggregate market value of $165,127.20. The filing notes no sales in the prior three months and includes the standard representation regarding material adverse information. For investors, this is a compliance disclosure of an intended transaction rather than a corporate operational update.

Corporate Governance Expert

TL;DR: The notice is procedurally complete and signals an insider liquidity event based on prior compensation awards.

The report identifies the securities as compensation-based restricted stock grants originally recorded on 04/01/2020 and confirms payment was in connection with compensation. The use of a broker and the absence of other recent sales are disclosed. The filing meets Rule 144 notification norms and provides the required seller attestation about undisclosed material information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2000	165127.2	15200000	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2020	Rest Stock Grants	Christopher Reading			3089	04/01/2020	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does USPH's Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 2,000 common shares via UBS Financial Services on the NYSE with aggregate market value of $165,127.20 and an approximate sale date of 09/04/2025.

When and how were the shares being sold by the USPH reporting person acquired?

The shares were acquired as restricted stock grants on 04/01/2020; the filing shows 3,089 shares were acquired and payment was recorded as compensation.

Has the reporting person sold any USPH securities in the past three months?

According to the Form 144, there is nothing to report for securities sold by the reporting person during the past three months.

Which broker and exchange are named for the proposed USPH sale?

The broker is UBS Financial Services Inc, 1000 Harbor Blvd, Weehawken NJ and the exchange named is the NYSE.

What representation does the seller make in the Form 144?

By signing the notice, the seller represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.